TITLE

Two percent of women have completed HPV vaccine since FDA approval

AUTHOR(S)
Sutherland, Andrea
PUB. DATE
July 2008
SOURCE
Hem/Onc Today;7/25/2008, Vol. 9 Issue 13, p18
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article reports that only two percent of the total number of eligible women in the U.S. have completed the human papillomavirus (HPV) vaccine in 2008. According to a survey conducted before the approval of HPV vaccine in 2006, physicians are likely to vaccinate their patients against HPV. However, 24 months after the HPV vaccine approval, medical audits found that only 10 percent of young women and girls have been vaccinated in the first quarter of 2008 and only two percent have completed the three doses.
ACCESSION #
33230001

 

Related Articles

  • Few women finished HPV vaccine regimen. Harris, Jason // Infectious Diseases in Children;Dec2010, Vol. 23 Issue 12, p35 

    The article reports that only one-third of the women who initiated human papillomavirus vaccine were only able to complete a full course of the vaccine.

  • Quadrivalent HPV vaccine safe, immunogenic in women with HIV. Shafer, Emily // Infectious Disease News;May2014, Vol. 27 Issue 5, p47 

    The article reports that the quadrivalent human papillomavirus (HPV) vaccine was safe and immunogenic among women aged 13 to 45 years with HIV, according to data published in "Clinical Infectious Diseases."

  • Few women finished HPV vaccine regimen. Volansky, Rob // Hem/Onc Today;12/10/2010, Vol. 11 Issue 23, p22 

    The article presents a study which showed that only one-third of young, urban women eligible for human papillomavirus (HPV) vaccine received it, of which only one-third completed the full course.

  • HPV VACCINES. SHAH, NIRVI // Education Week;7/10/2013, Vol. 32 Issue 36, p5 

    The article discusses the drop in incidents of human papillomavirus (HPV) in young women due to vaccines introduced in 2006, according to the study "Reduction of Human Papillomavirus Among Young Women Following HPV Vaccine Introduction in the United States" in the "Journal of Infectious Diseases."

  • Vaccines aren't the problem, understanding the science is. Turner, Nikki; Brandt, Theo // New Zealand Doctor;11/25/2015, p18 

    The authors argue on a television coverage about the relationship between HPV vaccine and illness in young people.

  • Comparing the HPV vaccines. Blamble, Deborah // Hem/Onc Today;3/25/2010, Vol. 11 Issue 6, p6 

    The article discusses various studies on human papillomavirus (HPV) vaccines, including quadrivalent and bivalent vaccines.

  • Combined support most effective in improving HPV vaccine delivery. Cox, Amber // Infectious Diseases in Children;Aug2013, Vol. 26 Issue 8, p29 

    The article reports on a study published in the journal "Pediatrics," which stated that clinicians and families must collaborate to effectively promote HPV vaccine series receipt.

  • Informe de la autoridad danesa de salud y medicamentos. Chaves-Ortiz, Verónica; Yepes, Francisco; Hernández, Luis Jorge // Revista Gerencia y Políticas de Salud;Jul-Dec2015, Vol. 14 Issue 29, p193 

    No abstract available.

  • Update on HPV vaccine: Will males be the next ones to receive immunization?  // Contraceptive Technology Update;Feb2009, Vol. 30 Issue 2, p13 

    The article reports on the human papillomavirus (HPV) vaccine as HPV prevention for males.

  • NEWSFLASH: THE HPV VACCINE. Bell, Kate // Cleo;Feb2003, Issue 364, p158 

    States that a vaccine against human papilloma virus has been developed and is undergoing trials as of February 2003.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics